Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Abstract Background Neuroendocrine prostate cancer (NEPC) may be rising in prevalence as patients with advanced prostate cancer potentially develop resistance to contemporary anti-androgen treatment through a neuroendocrine phenotype. While prior studies comparing NEPC and prostatic adenocarcinoma h...

Full description

Bibliographic Details
Main Authors: Harrison K. Tsai, Jonathan Lehrer, Mohammed Alshalalfa, Nicholas Erho, Elai Davicioni, Tamara L. Lotan
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Cancer
Subjects:
Neuroendocrine prostate cancer
Small cell carcinoma
Mixed prostatic adenocarcinoma
FFPE
Gene signature
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12885-017-3729-z

Internet

http://link.springer.com/article/10.1186/s12885-017-3729-z

Similar Items